Ακετυλοκυστεΐνη (Greek Wikipedia)

Analysis of information sources in references of the Wikipedia article "Ακετυλοκυστεΐνη" in Greek language version.

refsWebsite

Global rank Greek rank

43nih.gov

4^th place

31doi.org

2^nd place

3^rd place

10web.archive.org

1^st place

6archive.org

6^th place

5^th place

4books.google.com

3^rd place

6^th place

4worldcat.org

5^th place

8^th place

1drugs.com

399^th place

130^th place

1sigmaaldrich.com

924^th place

9,953^rd place

1umm.edu

9,624^th place

4,770^th place

1fda.gov

447^th place

368^th place

1heartofengland.nhs.uk

low place

1medscape.com

719^th place

579^th place

1tga.gov.au

3,984^th place

2,133^rd place

archive.org

«Pharmacokinetics of N-acetylcysteine in man». European Journal of Clinical Pharmacology 31 (2): 217–22. 1986. doi:10.1007/bf00606662. PMID 3803419. https://archive.org/details/sim_european-journal-of-clinical-pharmacology_1986-11_31_2/page/217.
«Comparison of oral and i.v. acetylcysteine in the treatment of acetaminophen poisoning». American Journal of Health-System Pharmacy 63 (19): 1821–7. Oct 2006. doi:10.2146/ajhp060050. PMID 16990628. https://archive.org/details/sim_american-journal-of-health-system-pharmacy_2006-10-01_63_19/page/n60.
«Management of anaphylactoid reactions to intravenous N-acetylcysteine». Annals of Emergency Medicine 31 (6): 710–5. Jun 1998. doi:10.1016/S0196-0644(98)70229-X. PMID 9624310. https://archive.org/details/sim_annals-of-emergency-medicine_1998-06_31_6/page/710.
«Risk factors in the development of adverse reactions to N-acetylcysteine in patients with paracetamol poisoning». British Journal of Clinical Pharmacology 51 (1): 87–91. Jan 2001. doi:10.1046/j.1365-2125.2001.01305.x. PMID 11167669. PMC 2014432. https://archive.org/details/sim_british-journal-of-clinical-pharmacology_2001-01_51_1/page/87.
«The efficacy of adjunctive N-acetylcysteine in major depressive disorder: a double-blind, randomized, placebo-controlled trial». The Journal of Clinical Psychiatry 75 (6): 628–36. Jun 2014. doi:10.4088/JCP.13m08454. PMID 25004186. https://archive.org/details/sim_journal-of-clinical-psychiatry_2014-06_75_6/page/628.
«S-nitrosothiols signal hypoxia-mimetic vascular pathology». The Journal of Clinical Investigation 117 (9): 2592–601. Sep 2007. doi:10.1172/JCI29444. PMID 17786245. PMC 1952618. https://archive.org/details/sim_journal-of-clinical-investigation_2007-09_117_9/page/2592.

books.google.com

Stockley, Robert A. (2008). Chronic Obstructive Pulmonary Disease a Practical Guide to Management. Chichester: John Wiley & Sons. σελ. 750. ISBN 9780470755280. Αρχειοθετήθηκε από το πρωτότυπο στις 8 Σεπτεμβρίου 2017.
Talbott, Shawn M. (2012). A Guide to Understanding Dietary Supplements (στα Αγγλικά). Routledge. σελ. 469. ISBN 9781136805707.
Fischer, János· Ganellin, C. Robin (2006). Analogue-Based Drug Discovery. Weinheim: Wiley-VCH. σελ. 544. ISBN 9783527607495.
Baker, Emma (2014). Top 100 drugs : clinical pharmacology and practical prescribing. σελ. Acetylcysteine. ISBN 9780702055157.

doi.org

dx.doi.org

Sadowska, Anna M; Verbraecken, J; Darquennes, K; De Backer, WA (December 2006). «Role of N-acetylcysteine in the management of COPD». International Journal of Chronic Obstructive Pulmonary Disease 1 (4): 425–434. doi:10.2147/copd.2006.1.4.425. ISSN 1176-9106. PMID 18044098.
«Oral and Intravenous Acetylcysteine for Treatment of Acetaminophen Toxicity: A Systematic Review and Meta-analysis». The Western Journal of Emergency Medicine 14 (3): 218–26. May 2013. doi:10.5811/westjem.2012.4.6885. PMID 23687539.
«Pharmacokinetics of N-acetylcysteine in man». European Journal of Clinical Pharmacology 31 (2): 217–22. 1986. doi:10.1007/bf00606662. PMID 3803419. https://archive.org/details/sim_european-journal-of-clinical-pharmacology_1986-11_31_2/page/217.
«Oral N-acetyl-L-cysteine is a safe and effective precursor of cysteine». Journal of Animal Science 85 (7): 1712–8. Jul 2007. doi:10.2527/jas.2006-835. PMID 17371789.
«Comparison of oral and i.v. acetylcysteine in the treatment of acetaminophen poisoning». American Journal of Health-System Pharmacy 63 (19): 1821–7. Oct 2006. doi:10.2146/ajhp060050. PMID 16990628. https://archive.org/details/sim_american-journal-of-health-system-pharmacy_2006-10-01_63_19/page/n60.
«Adverse reactions to N-acetylcysteine during treatment for paracetamol poisoning». The Medical Journal of Australia 150 (6): 329–31. Mar 1989. doi:10.5694/j.1326-5377.1989.tb136496.x. PMID 2716644.
«Management of anaphylactoid reactions to intravenous N-acetylcysteine». Annals of Emergency Medicine 31 (6): 710–5. Jun 1998. doi:10.1016/S0196-0644(98)70229-X. PMID 9624310. https://archive.org/details/sim_annals-of-emergency-medicine_1998-06_31_6/page/710.
«Risk factors in the development of adverse reactions to N-acetylcysteine in patients with paracetamol poisoning». British Journal of Clinical Pharmacology 51 (1): 87–91. Jan 2001. doi:10.1046/j.1365-2125.2001.01305.x. PMID 11167669. PMC 2014432. https://archive.org/details/sim_british-journal-of-clinical-pharmacology_2001-01_51_1/page/87.
«Anaphylactoid reactions to intravenous N-acetylcysteine: a prospective case controlled study». Accident and Emergency Nursing 12 (1): 10–5. Jan 2004. doi:10.1016/j.aaen.2003.07.001. PMID 14700565.
Tam, J; Nash, EF; Ratjen, F; Tullis, E; Stephenson, A (12 July 2013). «Nebulized and oral thiol derivatives for pulmonary disease in cystic fibrosis.». The Cochrane Database of Systematic Reviews (7): CD007168. doi:10.1002/14651858.CD007168.pub3. PMID 23852992. Αρχειοθετήθηκε από το πρωτότυπο στις 2017-09-22. https://web.archive.org/web/20170922002606/http://www.repository.heartofengland.nhs.uk/157/1/Nebulized%20and%20oral%20thiol%20derivatives%20for%20pulmonary%20disease%20in%20cystic%20fibrosis..pdf. Ανακτήθηκε στις 2020-10-26.
«Efficacy of oral long-term N-acetylcysteine in chronic bronchopulmonary disease: a meta-analysis of published double-blind, placebo-controlled clinical trials». Clinical Therapeutics 22 (2): 209–21. Feb 2000. doi:10.1016/S0149-2918(00)88479-9. PMID 10743980.
«The effect of oral N-acetylcysteine in chronic bronchitis: a quantitative systematic review». The European Respiratory Journal 16 (2): 253–62. Aug 2000. doi:10.1034/j.1399-3003.2000.16b12.x. PMID 10968500.
«Oral mucolytic drugs for exacerbations of chronic obstructive pulmonary disease: systematic review». BMJ 322 (7297): 1271–4. May 2001. doi:10.1136/bmj.322.7297.1271. PMID 11375228.
Pistolesi, V; Regolisti, G; Morabito, S; Gandolfini, I; Corrado, S; Piotti, G; Fiaccadori, E (December 2018). «Contrast medium induced acute kidney injury: a narrative review.». Journal of Nephrology 31 (6): 797–812. doi:10.1007/s40620-018-0498-y. PMID 29802583.
«N-acetylcysteine (NAC) in neurological disorders: mechanisms of action and therapeutic opportunities». Brain and Behavior 4 (2): 108–22. Mar 2014. doi:10.1002/brb3.208. PMID 24683506.
«N-acetylcysteine in psychiatry: current therapeutic evidence and potential mechanisms of action». Journal of Psychiatry & Neuroscience 36 (2): 78–86. Mar 2011. doi:10.1503/jpn.100057. PMID 21118657.
«The promise of N-acetylcysteine in neuropsychiatry». Trends in Pharmacological Sciences 34 (3): 167–77. Mar 2013. doi:10.1016/j.tips.2013.01.001. PMID 23369637.
«Clinical trials of N-acetylcysteine in psychiatry and neurology: A systematic review». Neuroscience and Biobehavioral Reviews 55: 294–321. Aug 2015. doi:10.1016/j.neubiorev.2015.04.015. PMID 25957927. «In this systematic review we find favorable evidence for the use of NAC in several psychiatric and neurological disorders, particularly autism, Alzheimer's disease, cocaine, bipolar disorder, depression, trichotillomania, nail biting, skin picking, obsessive-compulsive disorder, schizophrenia, drug-induced neuropathy and progressive myoclonic epilepsy. Disorders such as nicotine addictions, anxiety, attention deficit hyperactivity disorder and mild traumatic brain injury have preliminary evidence and require larger confirmatory studies while current evidence does not support the use of NAC in gambling, methamphetamine and amyotrophic lateral sclerosis. Overall, NAC treatment appears to be safe and tolerable.».
«The efficacy of adjunctive N-acetylcysteine in major depressive disorder: a double-blind, randomized, placebo-controlled trial». The Journal of Clinical Psychiatry 75 (6): 628–36. Jun 2014. doi:10.4088/JCP.13m08454. PMID 25004186. https://archive.org/details/sim_journal-of-clinical-psychiatry_2014-06_75_6/page/628.
«N-acetyl cysteine in the treatment of obsessive compulsive and related disorders: a systematic review». Clinical Psychopharmacology and Neuroscience 13 (1): 12–24. Apr 2015. doi:10.9758/cpn.2015.13.1.12. PMID 25912534.
«The chemistry and biological activities of N-acetylcysteine». Biochimica et Biophysica Acta (BBA) - General Subjects 1830 (8): 4117–29. Aug 2013. doi:10.1016/j.bbagen.2013.04.016. PMID 23618697.
Minarini, A; Ferrari, S; Galletti, M; Giambalvo, N; Perrone, D; Rioli, G; Galeazzi, GM (2 November 2016). «N-acetylcysteine in the treatment of psychiatric disorders: current status and future prospects.». Expert Opinion on Drug Metabolism & Toxicology 13 (3): 279–292. doi:10.1080/17425255.2017.1251580. PMID 27766914.
«S-nitrosothiols signal hypoxia-mimetic vascular pathology». The Journal of Clinical Investigation 117 (9): 2592–601. Sep 2007. doi:10.1172/JCI29444. PMID 17786245. PMC 1952618. https://archive.org/details/sim_journal-of-clinical-investigation_2007-09_117_9/page/2592.
«Effect of N-acetyl-cysteine on the hypoxic ventilatory response and erythropoietin production: linkage between plasma thiol redox state and O(2) chemosensitivity». Blood 99 (5): 1552–5. Mar 2002. doi:10.1182/blood.V99.5.1552. PMID 11861267.
«A dual effect of N-acetylcysteine on acute ethanol-induced liver damage in mice». Hepatology Research 34 (3): 199–206. Mar 2006. doi:10.1016/j.hepres.2005.12.005. PMID 16439183.
Steullet, P.; Neijt, H.C.; Cuénod, M.; Do, K.Q. (2006). «Synaptic plasticity impairment and hypofunction of NMDA receptors induced by glutathione deficit: Relevance to schizophrenia». Neuroscience 137 (3): 807–819. doi:10.1016/j.neuroscience.2005.10.014. ISSN 0306-4522. PMID 16330153.
Varga, V.; Jenei, Zs.; Janáky, R.; Saransaari, P.; Oja, S. S. (1997). «Glutathione Is an Endogenous Ligand of Rat Brain N-Methyl-D-Aspartate (NMDA) and 2-Amino-3-Hydroxy-5-Methyl-4-Isoxazolepropionate (AMPA) Receptors». Neurochemical Research 22 (9): 1165–1171. doi:10.1023/A:1027377605054. ISSN 0364-3190. PMID 9251108.
Oja, S (2000). «Modulation of glutamate receptor functions by glutathione». Neurochemistry International 37 (2–3): 299–306. doi:10.1016/S0197-0186(00)00031-0. ISSN 0197-0186. PMID 10812215.
«Glutathione precursor, N-acetyl-cysteine, improves mismatch negativity in schizophrenia patients». Neuropsychopharmacology 33 (9): 2187–99. Aug 2008. doi:10.1038/sj.npp.1301624. PMID 18004285.
«N-acetylcysteine for antioxidant therapy: pharmacology and clinical utility». Expert Opinion on Biological Therapy 8 (12): 1955–62. Dec 2008. doi:10.1517/14728220802517901. PMID 18990082.
«The effect of N-acetylcysteine in the nucleus accumbens on neurotransmission and relapse to cocaine». Biological Psychiatry 71 (11): 978–86. Jun 2012. doi:10.1016/j.biopsych.2011.10.024. PMID 22137594.

drugs.com

«Acetylcysteine». The American Society of Health-System Pharmacists. Αρχειοθετήθηκε από το πρωτότυπο στις 23 Σεπτεμβρίου 2015. Ανακτήθηκε στις 22 Αυγούστου 2015.

fda.gov

accessdata.fda.gov

«Acetadote Package Insert» (PDF). FDA. Αρχειοθετήθηκε από το πρωτότυπο (PDF) στις 25 Αυγούστου 2013. Ανακτήθηκε στις 19 Απριλίου 2014.

heartofengland.nhs.uk

repository.heartofengland.nhs.uk

Tam, J; Nash, EF; Ratjen, F; Tullis, E; Stephenson, A (12 July 2013). «Nebulized and oral thiol derivatives for pulmonary disease in cystic fibrosis.». The Cochrane Database of Systematic Reviews (7): CD007168. doi:10.1002/14651858.CD007168.pub3. PMID 23852992. Αρχειοθετήθηκε από το πρωτότυπο στις 2017-09-22. https://web.archive.org/web/20170922002606/http://www.repository.heartofengland.nhs.uk/157/1/Nebulized%20and%20oral%20thiol%20derivatives%20for%20pulmonary%20disease%20in%20cystic%20fibrosis..pdf. Ανακτήθηκε στις 2020-10-26.

medscape.com

emedicine.medscape.com

«Hemorrhagic Cystitis Treatment & Management: Approach Considerations, Clot Evacuation, Bladder Irrigation Agents». 5 Δεκεμβρίου 2019. Ανακτήθηκε στις 18 Δεκεμβρίου 2019.

nih.gov

ncbi.nlm.nih.gov

Sadowska, Anna M; Verbraecken, J; Darquennes, K; De Backer, WA (December 2006). «Role of N-acetylcysteine in the management of COPD». International Journal of Chronic Obstructive Pulmonary Disease 1 (4): 425–434. doi:10.2147/copd.2006.1.4.425. ISSN 1176-9106. PMID 18044098.
«Oral and Intravenous Acetylcysteine for Treatment of Acetaminophen Toxicity: A Systematic Review and Meta-analysis». The Western Journal of Emergency Medicine 14 (3): 218–26. May 2013. doi:10.5811/westjem.2012.4.6885. PMID 23687539.
«Pharmacokinetics of N-acetylcysteine in man». European Journal of Clinical Pharmacology 31 (2): 217–22. 1986. doi:10.1007/bf00606662. PMID 3803419. https://archive.org/details/sim_european-journal-of-clinical-pharmacology_1986-11_31_2/page/217.
«Oral N-acetyl-L-cysteine is a safe and effective precursor of cysteine». Journal of Animal Science 85 (7): 1712–8. Jul 2007. doi:10.2527/jas.2006-835. PMID 17371789.
«Comparison of oral and i.v. acetylcysteine in the treatment of acetaminophen poisoning». American Journal of Health-System Pharmacy 63 (19): 1821–7. Oct 2006. doi:10.2146/ajhp060050. PMID 16990628. https://archive.org/details/sim_american-journal-of-health-system-pharmacy_2006-10-01_63_19/page/n60.
«Adverse reactions to N-acetylcysteine during treatment for paracetamol poisoning». The Medical Journal of Australia 150 (6): 329–31. Mar 1989. doi:10.5694/j.1326-5377.1989.tb136496.x. PMID 2716644.
«Management of anaphylactoid reactions to intravenous N-acetylcysteine». Annals of Emergency Medicine 31 (6): 710–5. Jun 1998. doi:10.1016/S0196-0644(98)70229-X. PMID 9624310. https://archive.org/details/sim_annals-of-emergency-medicine_1998-06_31_6/page/710.
«Risk factors in the development of adverse reactions to N-acetylcysteine in patients with paracetamol poisoning». British Journal of Clinical Pharmacology 51 (1): 87–91. Jan 2001. doi:10.1046/j.1365-2125.2001.01305.x. PMID 11167669. PMC 2014432. https://archive.org/details/sim_british-journal-of-clinical-pharmacology_2001-01_51_1/page/87.
«Anaphylactoid reactions to intravenous N-acetylcysteine: a prospective case controlled study». Accident and Emergency Nursing 12 (1): 10–5. Jan 2004. doi:10.1016/j.aaen.2003.07.001. PMID 14700565.
Tam, J; Nash, EF; Ratjen, F; Tullis, E; Stephenson, A (12 July 2013). «Nebulized and oral thiol derivatives for pulmonary disease in cystic fibrosis.». The Cochrane Database of Systematic Reviews (7): CD007168. doi:10.1002/14651858.CD007168.pub3. PMID 23852992. Αρχειοθετήθηκε από το πρωτότυπο στις 2017-09-22. https://web.archive.org/web/20170922002606/http://www.repository.heartofengland.nhs.uk/157/1/Nebulized%20and%20oral%20thiol%20derivatives%20for%20pulmonary%20disease%20in%20cystic%20fibrosis..pdf. Ανακτήθηκε στις 2020-10-26.
«Efficacy of oral long-term N-acetylcysteine in chronic bronchopulmonary disease: a meta-analysis of published double-blind, placebo-controlled clinical trials». Clinical Therapeutics 22 (2): 209–21. Feb 2000. doi:10.1016/S0149-2918(00)88479-9. PMID 10743980.
«The effect of oral N-acetylcysteine in chronic bronchitis: a quantitative systematic review». The European Respiratory Journal 16 (2): 253–62. Aug 2000. doi:10.1034/j.1399-3003.2000.16b12.x. PMID 10968500.
«Oral mucolytic drugs for exacerbations of chronic obstructive pulmonary disease: systematic review». BMJ 322 (7297): 1271–4. May 2001. doi:10.1136/bmj.322.7297.1271. PMID 11375228.
Pistolesi, V; Regolisti, G; Morabito, S; Gandolfini, I; Corrado, S; Piotti, G; Fiaccadori, E (December 2018). «Contrast medium induced acute kidney injury: a narrative review.». Journal of Nephrology 31 (6): 797–812. doi:10.1007/s40620-018-0498-y. PMID 29802583.
«N-acetylcysteine (NAC) in neurological disorders: mechanisms of action and therapeutic opportunities». Brain and Behavior 4 (2): 108–22. Mar 2014. doi:10.1002/brb3.208. PMID 24683506.
«N-acetylcysteine in psychiatry: current therapeutic evidence and potential mechanisms of action». Journal of Psychiatry & Neuroscience 36 (2): 78–86. Mar 2011. doi:10.1503/jpn.100057. PMID 21118657.
«The promise of N-acetylcysteine in neuropsychiatry». Trends in Pharmacological Sciences 34 (3): 167–77. Mar 2013. doi:10.1016/j.tips.2013.01.001. PMID 23369637.
«Clinical trials of N-acetylcysteine in psychiatry and neurology: A systematic review». Neuroscience and Biobehavioral Reviews 55: 294–321. Aug 2015. doi:10.1016/j.neubiorev.2015.04.015. PMID 25957927. «In this systematic review we find favorable evidence for the use of NAC in several psychiatric and neurological disorders, particularly autism, Alzheimer's disease, cocaine, bipolar disorder, depression, trichotillomania, nail biting, skin picking, obsessive-compulsive disorder, schizophrenia, drug-induced neuropathy and progressive myoclonic epilepsy. Disorders such as nicotine addictions, anxiety, attention deficit hyperactivity disorder and mild traumatic brain injury have preliminary evidence and require larger confirmatory studies while current evidence does not support the use of NAC in gambling, methamphetamine and amyotrophic lateral sclerosis. Overall, NAC treatment appears to be safe and tolerable.».
«The efficacy of adjunctive N-acetylcysteine in major depressive disorder: a double-blind, randomized, placebo-controlled trial». The Journal of Clinical Psychiatry 75 (6): 628–36. Jun 2014. doi:10.4088/JCP.13m08454. PMID 25004186. https://archive.org/details/sim_journal-of-clinical-psychiatry_2014-06_75_6/page/628.
«N-acetyl cysteine in the treatment of obsessive compulsive and related disorders: a systematic review». Clinical Psychopharmacology and Neuroscience 13 (1): 12–24. Apr 2015. doi:10.9758/cpn.2015.13.1.12. PMID 25912534.
«The chemistry and biological activities of N-acetylcysteine». Biochimica et Biophysica Acta (BBA) - General Subjects 1830 (8): 4117–29. Aug 2013. doi:10.1016/j.bbagen.2013.04.016. PMID 23618697.
Minarini, A; Ferrari, S; Galletti, M; Giambalvo, N; Perrone, D; Rioli, G; Galeazzi, GM (2 November 2016). «N-acetylcysteine in the treatment of psychiatric disorders: current status and future prospects.». Expert Opinion on Drug Metabolism & Toxicology 13 (3): 279–292. doi:10.1080/17425255.2017.1251580. PMID 27766914.
«S-nitrosothiols signal hypoxia-mimetic vascular pathology». The Journal of Clinical Investigation 117 (9): 2592–601. Sep 2007. doi:10.1172/JCI29444. PMID 17786245. PMC 1952618. https://archive.org/details/sim_journal-of-clinical-investigation_2007-09_117_9/page/2592.
«Effect of N-acetyl-cysteine on the hypoxic ventilatory response and erythropoietin production: linkage between plasma thiol redox state and O(2) chemosensitivity». Blood 99 (5): 1552–5. Mar 2002. doi:10.1182/blood.V99.5.1552. PMID 11861267.
«A dual effect of N-acetylcysteine on acute ethanol-induced liver damage in mice». Hepatology Research 34 (3): 199–206. Mar 2006. doi:10.1016/j.hepres.2005.12.005. PMID 16439183.
Steullet, P.; Neijt, H.C.; Cuénod, M.; Do, K.Q. (2006). «Synaptic plasticity impairment and hypofunction of NMDA receptors induced by glutathione deficit: Relevance to schizophrenia». Neuroscience 137 (3): 807–819. doi:10.1016/j.neuroscience.2005.10.014. ISSN 0306-4522. PMID 16330153.
Varga, V.; Jenei, Zs.; Janáky, R.; Saransaari, P.; Oja, S. S. (1997). «Glutathione Is an Endogenous Ligand of Rat Brain N-Methyl-D-Aspartate (NMDA) and 2-Amino-3-Hydroxy-5-Methyl-4-Isoxazolepropionate (AMPA) Receptors». Neurochemical Research 22 (9): 1165–1171. doi:10.1023/A:1027377605054. ISSN 0364-3190. PMID 9251108.
Oja, S (2000). «Modulation of glutamate receptor functions by glutathione». Neurochemistry International 37 (2–3): 299–306. doi:10.1016/S0197-0186(00)00031-0. ISSN 0197-0186. PMID 10812215.
«Glutathione precursor, N-acetyl-cysteine, improves mismatch negativity in schizophrenia patients». Neuropsychopharmacology 33 (9): 2187–99. Aug 2008. doi:10.1038/sj.npp.1301624. PMID 18004285.
«N-acetylcysteine for antioxidant therapy: pharmacology and clinical utility». Expert Opinion on Biological Therapy 8 (12): 1955–62. Dec 2008. doi:10.1517/14728220802517901. PMID 18990082.
«The effect of N-acetylcysteine in the nucleus accumbens on neurotransmission and relapse to cocaine». Biological Psychiatry 71 (11): 978–86. Jun 2012. doi:10.1016/j.biopsych.2011.10.024. PMID 22137594.

pubmedcentral.nih.gov

Sadowska, Anna M; Verbraecken, J; Darquennes, K; De Backer, WA (December 2006). «Role of N-acetylcysteine in the management of COPD». International Journal of Chronic Obstructive Pulmonary Disease 1 (4): 425–434. doi:10.2147/copd.2006.1.4.425. ISSN 1176-9106. PMID 18044098.
«Oral and Intravenous Acetylcysteine for Treatment of Acetaminophen Toxicity: A Systematic Review and Meta-analysis». The Western Journal of Emergency Medicine 14 (3): 218–26. May 2013. doi:10.5811/westjem.2012.4.6885. PMID 23687539.
«Risk factors in the development of adverse reactions to N-acetylcysteine in patients with paracetamol poisoning». British Journal of Clinical Pharmacology 51 (1): 87–91. Jan 2001. doi:10.1046/j.1365-2125.2001.01305.x. PMID 11167669. PMC 2014432. https://archive.org/details/sim_british-journal-of-clinical-pharmacology_2001-01_51_1/page/87.
«Oral mucolytic drugs for exacerbations of chronic obstructive pulmonary disease: systematic review». BMJ 322 (7297): 1271–4. May 2001. doi:10.1136/bmj.322.7297.1271. PMID 11375228.
«N-acetylcysteine (NAC) in neurological disorders: mechanisms of action and therapeutic opportunities». Brain and Behavior 4 (2): 108–22. Mar 2014. doi:10.1002/brb3.208. PMID 24683506.
«N-acetylcysteine in psychiatry: current therapeutic evidence and potential mechanisms of action». Journal of Psychiatry & Neuroscience 36 (2): 78–86. Mar 2011. doi:10.1503/jpn.100057. PMID 21118657.
«N-acetyl cysteine in the treatment of obsessive compulsive and related disorders: a systematic review». Clinical Psychopharmacology and Neuroscience 13 (1): 12–24. Apr 2015. doi:10.9758/cpn.2015.13.1.12. PMID 25912534.
«S-nitrosothiols signal hypoxia-mimetic vascular pathology». The Journal of Clinical Investigation 117 (9): 2592–601. Sep 2007. doi:10.1172/JCI29444. PMID 17786245. PMC 1952618. https://archive.org/details/sim_journal-of-clinical-investigation_2007-09_117_9/page/2592.
«The effect of N-acetylcysteine in the nucleus accumbens on neurotransmission and relapse to cocaine». Biological Psychiatry 71 (11): 978–86. Jun 2012. doi:10.1016/j.biopsych.2011.10.024. PMID 22137594.

dailymed.nlm.nih.gov

«ACETADOTE (acetylcysteine) injection, solution [Cumberland Pharmaceuticals Inc.]». DailyMed. Cumberland Pharmaceuticals Inc. Ιουνίου 2013. Αρχειοθετήθηκε από το πρωτότυπο στις 13 Ιανουαρίου 2014. Ανακτήθηκε στις 8 Νοεμβρίου 2013.
«Mucomyst Package Insert». Αρχειοθετήθηκε από το πρωτότυπο στις 21 Απριλίου 2014. Ανακτήθηκε στις 20 Απριλίου 2014.

pubchem.ncbi.nlm.nih.gov

«L-Cysteine, N-acetyl- - Compound Summary». PubChem Compound. USA: National Center for Biotechnology Information. 25 Μαρτίου 2005. Identification. Αρχειοθετήθηκε από το πρωτότυπο στις 12 Ιανουαρίου 2014. Ανακτήθηκε στις 9 Ιανουαρίου 2012.

sigmaaldrich.com

«N-ACETYL-L-CYSTEINE Product Information» (PDF). Sigma. Sigma-aldrich. Αρχειοθετήθηκε από το πρωτότυπο (PDF) στις 11 Ιουνίου 2014. Ανακτήθηκε στις 9 Νοεμβρίου 2014.

tga.gov.au

ebs.tga.gov.au

«PRODUCT INFORMATION ACETADOTE® CONCENTRATED INJECTION». TGA eBusiness Services. Phebra Pty Ltd. 16 Ιανουαρίου 2013. Αρχειοθετήθηκε από το πρωτότυπο (PDF) στις 8 Σεπτεμβρίου 2017. Ανακτήθηκε στις 8 Νοεμβρίου 2013.

umm.edu

«Cysteine». University of Maryland Medical Center (στα Αγγλικά). Αρχειοθετήθηκε από το πρωτότυπο στις 1 Ιουλίου 2017. Ανακτήθηκε στις 23 Ιουνίου 2017.

web.archive.org

«L-Cysteine, N-acetyl- - Compound Summary». PubChem Compound. USA: National Center for Biotechnology Information. 25 Μαρτίου 2005. Identification. Αρχειοθετήθηκε από το πρωτότυπο στις 12 Ιανουαρίου 2014. Ανακτήθηκε στις 9 Ιανουαρίου 2012.
Stockley, Robert A. (2008). Chronic Obstructive Pulmonary Disease a Practical Guide to Management. Chichester: John Wiley & Sons. σελ. 750. ISBN 9780470755280. Αρχειοθετήθηκε από το πρωτότυπο στις 8 Σεπτεμβρίου 2017.
«Acetylcysteine». The American Society of Health-System Pharmacists. Αρχειοθετήθηκε από το πρωτότυπο στις 23 Σεπτεμβρίου 2015. Ανακτήθηκε στις 22 Αυγούστου 2015.
«ACETADOTE (acetylcysteine) injection, solution [Cumberland Pharmaceuticals Inc.]». DailyMed. Cumberland Pharmaceuticals Inc. Ιουνίου 2013. Αρχειοθετήθηκε από το πρωτότυπο στις 13 Ιανουαρίου 2014. Ανακτήθηκε στις 8 Νοεμβρίου 2013.
«N-ACETYL-L-CYSTEINE Product Information» (PDF). Sigma. Sigma-aldrich. Αρχειοθετήθηκε από το πρωτότυπο (PDF) στις 11 Ιουνίου 2014. Ανακτήθηκε στις 9 Νοεμβρίου 2014.
«Cysteine». University of Maryland Medical Center (στα Αγγλικά). Αρχειοθετήθηκε από το πρωτότυπο στις 1 Ιουλίου 2017. Ανακτήθηκε στις 23 Ιουνίου 2017.
«Acetadote Package Insert» (PDF). FDA. Αρχειοθετήθηκε από το πρωτότυπο (PDF) στις 25 Αυγούστου 2013. Ανακτήθηκε στις 19 Απριλίου 2014.
Tam, J; Nash, EF; Ratjen, F; Tullis, E; Stephenson, A (12 July 2013). «Nebulized and oral thiol derivatives for pulmonary disease in cystic fibrosis.». The Cochrane Database of Systematic Reviews (7): CD007168. doi:10.1002/14651858.CD007168.pub3. PMID 23852992. Αρχειοθετήθηκε από το πρωτότυπο στις 2017-09-22. https://web.archive.org/web/20170922002606/http://www.repository.heartofengland.nhs.uk/157/1/Nebulized%20and%20oral%20thiol%20derivatives%20for%20pulmonary%20disease%20in%20cystic%20fibrosis..pdf. Ανακτήθηκε στις 2020-10-26.
«Mucomyst Package Insert». Αρχειοθετήθηκε από το πρωτότυπο στις 21 Απριλίου 2014. Ανακτήθηκε στις 20 Απριλίου 2014.
«PRODUCT INFORMATION ACETADOTE® CONCENTRATED INJECTION». TGA eBusiness Services. Phebra Pty Ltd. 16 Ιανουαρίου 2013. Αρχειοθετήθηκε από το πρωτότυπο (PDF) στις 8 Σεπτεμβρίου 2017. Ανακτήθηκε στις 8 Νοεμβρίου 2013.

worldcat.org

Sadowska, Anna M; Verbraecken, J; Darquennes, K; De Backer, WA (December 2006). «Role of N-acetylcysteine in the management of COPD». International Journal of Chronic Obstructive Pulmonary Disease 1 (4): 425–434. doi:10.2147/copd.2006.1.4.425. ISSN 1176-9106. PMID 18044098.
Steullet, P.; Neijt, H.C.; Cuénod, M.; Do, K.Q. (2006). «Synaptic plasticity impairment and hypofunction of NMDA receptors induced by glutathione deficit: Relevance to schizophrenia». Neuroscience 137 (3): 807–819. doi:10.1016/j.neuroscience.2005.10.014. ISSN 0306-4522. PMID 16330153.
Varga, V.; Jenei, Zs.; Janáky, R.; Saransaari, P.; Oja, S. S. (1997). «Glutathione Is an Endogenous Ligand of Rat Brain N-Methyl-D-Aspartate (NMDA) and 2-Amino-3-Hydroxy-5-Methyl-4-Isoxazolepropionate (AMPA) Receptors». Neurochemical Research 22 (9): 1165–1171. doi:10.1023/A:1027377605054. ISSN 0364-3190. PMID 9251108.
Oja, S (2000). «Modulation of glutamate receptor functions by glutathione». Neurochemistry International 37 (2–3): 299–306. doi:10.1016/S0197-0186(00)00031-0. ISSN 0197-0186. PMID 10812215.